Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

PacWest Banc Q2 EPS $1.52 Beats $0.97 Estimate

PacWest Banc (NASDAQ:PACW) reported quarterly earnings of $1.52 per share which beat the analyst consensus estimate of $0.97 by 56.7 percent. This is a 442.86 percent increase over earnings of $0.28 per share from the
byBill Haddad
July 19, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

PacWest Banc (NASDAQ:PACW) reported quarterly earnings of $1.52 per share which beat the analyst consensus estimate of $0.97 by 56.7 percent. This is a 442.86 percent increase over earnings of $0.28 per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

FDA Accepted Submission of Supplemental New Drug Application for LYNPARZA in Combination With Abiraterone and Prednisone or Prednisolone for Patients With Metastatic Castration-Resistant Prostate Cancer and Grants Priority Review

By Charles Gross
Today, 11:48 PM
AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that a supplemental New Drug Application (sNDA) for LYNPARZA in combination with abiraterone and prednisone or prednisolone has been accepted and granted priority review by the U.S.

AZN